News & Events

The 10-part series will explore the benefits this technology to patients with novel delivery forms and product capabilities while also providing product differentiation and IP protection for pharmaceutical companies seeking innovation for their oral drug products and product candidates from early development through commercial manufacturing.

There is no cost to attend and registration information is provided below.  Additionally, this webinar will be recorded for future viewing for registered attendees if the times are not conducive to their schedule at the time of airing.  The first 1-hour session in the series is on September 14^th at 11:00 AM EST, with the second and third sessions October 5th and November 2nd. Check back as more sessions are announced.

For more information and the registration link – https://bit.ly/2WIisEA